Profile | GDS2987 / GI_41146732-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 6.9 | 25 |
GSM215244 | HMVEC_vehicle_rep2 | 51.1 | 69 |
GSM215253 | HMVEC_vehicle_rep3 | 30 | 63 |
GSM215254 | HMVEC_atorvastatin_rep1 | 35.7 | 63 |
GSM215282 | HMVEC_atorvastatin_rep3 | 31.7 | 57 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 80.9 | 73 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 5.5 | 12 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 54.1 | 63 |
GSM215294 | HMVEC_SLx2119_rep1 | 26.6 | 62 |
GSM215295 | HMVEC_SLx2119_rep2 | 14.1 | 28 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | 14.6 | 23 |
GSM215298 | PASMC_vehicle_rep2 | 30.3 | 43 |
GSM215310 | PASMC_vehicle_rep3 | 119.2 | 76 |
GSM215311 | PASMC_atorvastatin_rep1 | 52.9 | 64 |
GSM215312 | PASMC_atorvastatin_rep2 | 66.7 | 67 |
GSM215313 | PASMC_atorvastatin_rep3 | 51.6 | 59 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 32.5 | 48 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 12.2 | 24 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 50.3 | 62 |
GSM215327 | PASMC_SLx2119_rep1 | 29.4 | 46 |
GSM215328 | PASMC_SLx2119_rep2 | 51.1 | 64 |
GSM215329 | PASMC_SLx2119_rep3 | 32 | 51 |
GSM215330 | Fibroblasts_vehicle_rep1 | 7.9 | 19 |
GSM215331 | Fibroblasts_vehicle_rep2 | 9.7 | 27 |
GSM215332 | Fibroblasts_vehicle_rep3 | 15.3 | 45 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 13 | 33 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 36.2 | 63 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 24.3 | 50 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 33.1 | 64 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 31.6 | 64 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 19.1 | 47 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 5.5 | 17 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 23 | 52 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 23.8 | 50 |